Treatment costs for depression with pain and cardiovascular comorbidities

Journal of Psychiatric Research

Volumn 47, Issue 3, 2013, Pages 329-336

  Pan, Yi Ju ^a,b   Knapp, Martin ^a,c   Yeh, Ling Ling ^d   Chen, Yu Pei ^d   McCrone, Paul ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Cardiovascular disease; Comorbidity; Cost; Depression; Pain

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUPENTIXOL; MELITRACEN; MIRTAZAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NATIONAL HEALTH INSURANCE; PAIN; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RISK FACTOR; SYMPTOM; TAIWAN;

EID: 84873566486     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.11.005     Document Type: Article

References (39)

1. Albus C., Beutel M.E., Deter H.C., Fritzsche K., Hellmich M., Jordan J., et al. A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design of a multicenter, randomized trial in depressed patients with CAD. Journal of Psychosomatic Research 2011, 71:215-222.
2. Bair M.J., Robinson R.L., Eckert G.J., Stang P.E., Croghan T.W., Kroenke K. Impact of pain on depression treatment response in primary care. Psychosomatic Medicine 2004, 66:17-22.
3. Bair M.J., Robinson R.L., Katon W., Kroenke K. Depression and pain comorbidity: a literature review. Archives of Internal Medicine 2003, 163:2433-2445.
4. Barry D.T., Pilver C., Potenza M.N., Desai R.A. Prevalence and psychiatric correlates of pain interference among men and women in the general population. Journal of Psychiatric Research 2012, 46:118-127.
5. Barth J., Schumacher M., Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic Medicine 2004, 66:802-813.
6. Carney R.M., Rich M.W., Freedland K.E., Saini J., teVelde A., Simeone C., et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosomatic Medicine 1988, 50:627-633.
7. Chan A.L., Yang T.C., Chen J.X., Yu L.H., Leung H.W. Cost of depression of adults in Taiwan. The International Journal of Psychiatry in Medicine 2006, 36:131-135.
8. Chien I.C., Bih S.H., Chou Y.J., Lin C.H., Lee W.G., Chou P. Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997-2004. Psychiatric Services 2007, 58:554-557.
9. Coupland N., Wilson S., Nutt D. Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems. Journal of Psychopharmacology 1997, 11:83-92.
10. Denollet J., Schiffer A.A., Spek V. A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the type D (distressed) personality profile. Circulation: Cardiovascular Quality and Outcomes 2010, 3:546-557.
11. Fava M., Mallinckrodt C.H., Detke M.J., Watkin J.G., Wohlreich M.M. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?. Journal of Clinical Psychiatry 2004, 65:521-530.
12. Ferketich A.K., Schwartzbaum J.A., Frid D.J., Moeschberger M.L. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Archives of Internal Medicine 2000, 160:1261-1268.
13. Frasure-Smith N., Lesperance F. Depression and cardiac risk: present status and future directions. Heart 2010, 96:173-176.
14. Gameroff M.J., Olfson M. Major depressive disorder, somatic pain, and health care costs in an urban primary care practice. Journal of Clinical Psychiatry 2006, 67:1232-1239.
15. Giesecke T., Gracely R.H., Williams D.A., Geisser M.E., Petzke F.W., Clauw D.J. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis & Rheumatism 2005, 52:1577-1584.
16. Husain M.M., Rush A.J., Trivedi M.H., McClintock S.M., Wisniewski S.R., Davis L., et al. Pain in depression: STAR*D study findings. Journal of Psychosomatic Research 2007, 63:113-122.
17. Husaini B.A., Sherkat D.E., Levine R., Bragg R., Holzer C., Anderson K., et al. Race, gender, and health care service utilization and costs among medicare elderly with psychiatric diagnoses. Journal of Aging and Health 2002, 14:79-95.
18. Katon W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry 2003, 54:216-226.
19. Leuchter A.F., Husain M.M., Cook I.A., Trivedi M.H., Wisniewski S.R., Gilmer W.S., et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychological Medicine 2010, 40:239-251.
20. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006, 3:e442.
21. McCullagh P., Nelder J. Generalized linear models 1989, Chapman and Hall, London.
22. van Melle J.P., de Jonge P., Spijkerman T.A., Tijssen J.G., Ormel J., van Veldhuisen D.J., et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosomatic Medicine 2004, 66:814-822.
23. Nicholson A., Kuper H., Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. European Heart Journal 2006, 27:2763-2774.
24. Ohayon M.M., Schatzberg A.F. Chronic pain and major depressive disorder in the general population. Journal of Psychiatric Research 2010, 44:454-461.
25. Ohayon M.M., Schatzberg A.F. Using chronic pain to predict depressive morbidity in the general population. Archives of General Psychiatry 2003, 60:39-47.
26. Ohayon M.M., Stingl J.C. Prevalence and comorbidity of chronic pain in the German general population. Journal of Psychiatric Research 2012, 46:444-450.
27. Owens G.M. Gender differences in health care expenditures, resource utilization, and quality of care. Journal of Managed Care Pharmacy 2008, 14:2-6.
28. Pan Y.J., Knapp M., McCrone P. Cost-effectiveness comparisons between antidepressant treatments in depression: evidence from database analyses and prospective studies. Journal of Affective Disorders 2012, 139:113-125.
29. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. Journal of the American College of Cardiology 2005, 45:637-651.
30. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. American Journal of Preventive Medicine 2002, 23:51-61.
31. Sesso H.D., Kawachi I., Vokonas P.S., Sparrow D. Depression and the risk of coronary heart disease in the Normative Aging Study. American Journal of Cardiology 1998, 82:851-856.
32. Sorensenf C., Friis-Hasche E., Haghfelt T., Bech P. Postmyocardial infarction mortality in relation to depression: a systematic critical review. Psychotherapy and Psychosomatics 2005, 74:69-80.
33. Taylor D. Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Acta Psychiatrica Scandinavica 2008, 118:434-442.
34. Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., et al. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 2006, 21:30-38.
35. Vieweg W.V., Wood M.A. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics 2004, 45:371-377.
36. Wassertheil-Smoller S., Shumaker S., Ockene J., Talavera G.A., Greenland P., Cochrane B., et al. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Archives of Internal Medicine 2004, 164:289-298.
37. WHO The global burden of disease: 2004 update 2008, WHO Press.
38. Woolhandler S., Himmelstein D.U. Consumer directed healthcare: except for the healthy and wealthy it's unwise. Journal of General Internal Medicine 2007, 22:879-881.
39. Zheng B., Agresti A. Summarizing the predictive power of a generalized linear model. Statistics in Medicine 2000, 19:1771-1781.